20.06.2013
- Forest Laboratories, the specialty drugmaker that counts investor Carl Icahn as a major shareholder, is among a handful of companies interested in bidding for Irish drugmaker Elan...
15.01.2013
- Forest Laboratories posted an unexpectedly large loss in its fiscal third quarter as sales of its antidepressant Lexapro were buffeted by generic competition and sales of its...
16.08.2012
- Billionaire investor Carl Icahn has secured one out of four board seats he sought at drugmaker Forest Laboratories in a bitter proxy fight, according to an early tally of...
18.07.2012
- Large investors in U.S. biotech companies are likely to capture serious windfall profits as deal activity picks up in the sector. A Reuters analysis of investors' average cost...
11.07.2012
- The boards of BlackRock , Merck & Co and Caterpillar topped a ranking of the most capable boards of directors in corporate America, while a publicly traded affiliate of activist...
02.06.2012
- AstraZeneca and Bristol-Myers Squibb are among several pharmaceutical giants that have submitted initial bids for Amylin Pharmaceuticals, the diabetes drugmaker that is exploring a...
30.05.2012
- Billionaire investor Carl Icahn, who last year failed to get his nominees elected to the board of Forest Laboratories, plans to back another slate of directors at the drugmaker's...
09.04.2012
- Carl Icahn sued Amylin Pharmaceuticals on Monday to extend a deadline for nominating directors, as the activist investor pushes to win enough board seats to engineer a sale of the...
